Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4456 studies found for:    "Kidney Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
"Kidney Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
2 Recruiting New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Kidney Disease
Intervention:
3 Completed Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
Conditions: Chronic Kidney Disease;   Chronic Kidney Failure;   End Stage Kidney Disease;   End Stage Renal Disease
Intervention: Drug: N-acetylcysteine
4 Enrolling by invitation Mechanisms of Diabetic Nephropathy in Ecuador
Conditions: Diabetic Nephropathy;   Diabetes Mellitus;   Kidney Diseases;   Diabetic Kidney Disease;   Chronic Kidney Disease
Intervention:
5 Completed
Has Results
Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease
Conditions: Diabetes Mellitus;   Chronic Kidney Disease;   Diabetic Kidney Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
6 Completed
Has Results
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Coronary Artery Calcification;   Vascular Calcification;   Calcification;   Cardiovascular Disease;   Chronic Renal Failure;   Hyperparathyroidism;   Kidney Disease;   Nephrology;   Secondary Hyperparathyroidism
Intervention: Drug: cinacalcet
7 Completed Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Polycystic Kidney, Autosomal Dominant
Intervention:
8 Recruiting Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
9 Completed 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan MR;   Drug: Tolvaptan IR;   Drug: Placebo
10 Withdrawn Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
Conditions: Chronic Kidney Disease;   Kidney Disease
Interventions: Drug: MK-0677;   Drug: Placebo
11 Completed A Study in Patients With Diabetic Kidney Disease
Conditions: Diabetic Kidney Disease;   Diabetic Nephropathy;   Diabetic Glomerulosclerosis
Interventions: Drug: LY2382770;   Drug: Placebo
12 Recruiting Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells
13 Recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
14 Completed Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: darbepoetin alfa SF
15 Completed Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: Darbepoetin Alfa
16 Enrolling by invitation Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
17 Completed Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tetracosactin
18 Completed Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: Cinacalcet HCl
19 Terminated Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Conditions: Anemia;   Chronic Kidney Disease;   Kidney Disease
Interventions: Drug: darbepoetin alfa QW;   Drug: darbepoetin alfa Q2W
20 Completed START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism
Conditions: Kidney Disease;   Secondary Hyperparathyroidism;   Chronic Kidney Disease
Intervention: Drug: Sensipar

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years